Mark Dybul - 19 Jul 2021 Form 4 Insider Report for Enochian Biosciences Inc (RENB)

Role
Chief Executive Officer, Director
Signature
/s/ Mark R. Dybul
Issuer symbol
RENB
Transactions as of
19 Jul 2021
Net transactions value
$0
Form type
4
Filing time
22 Jul 2021, 16:33:09 UTC
Next filing
15 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RENB Option to purchase shares of common stock Award $0 +2,000,000 $0.000000 2,000,000 19 Jul 2021 Common stock 2,000,000 $4.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest ratably on July 1, 2022, July 1, 2023 and July 1, 2024.